AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding AIM ImmunoTech Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 33 | 36 | +3 |
| Shares | 4.09M | 8.44M | +4.35M (+106.3%) |
| Value | $1.93M | $3.15M | +$1.22M (+63.2%) |
New holders (6)
Institutions that held AIM ImmunoTech Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 4,078,000 | $1.52M | 0.04% |
| Citadel Advisors LLC | 98,027 | $36.5K | 0.00% |
| Virtu Financial LLC | 56,200 | $21.0K | 0.00% |
| CIBC Private Wealth Group, LLC | 5,000 | $1.84K | 0.00% |
| Cypress Capital, LLC | 200 | $75 | 0.00% |
| TD Waterhouse Canada Inc. | 170 | $63 | 0.00% |
Sold out (3)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| DRW Securities, LLC | 24,000 | $11.3K |
| Susquehanna International Group, LLP | 16,830 | $7.93K |
| FMR LLC | 521 | $245 |